Sterile protection againstP. vivaxmalaria by repeated blood stage infection in theAotusmonkey model

Abstract

The malaria parasitePlasmodium vivaxremains a major global public health challenge, and no vaccine is approved for use in humans. Here, we assessed whetherP. vivaxstrain-transcendent immunity can be achieved by repeated infection inAotusmonkeys. Sterile immunity was achieved after two homologous infections, whereas subsequent heterologous challenge provided only partial protection. IgG levels based onP. vivaxlysate ELISA and protein microarray increased with repeated infections and correlated with the level of homologous protection. Parasite transcriptional profiles provided no evidence of major antigenic switching upon homologous or heterologous challenge. However, we observed significant sequence diversity and transcriptional differences in theP. vivaxcore gene repertoire between the two strains used in the study, suggesting that partial protection upon heterologous challenge is due to molecular differences between strains rather than immune evasion by antigenic switching. Our study demonstrates that sterile immunity againstP. vivaxcan be achieved by repeated homologous blood stage infection inAotusmonkeys, thus providing a benchmark to test the efficacy of candidate blood stageP. vivaxmalaria vaccines.